Share this article
Share this article
ResearchAndMarkets.com s offering.
The Indian Molecular Diagnostics Market stood at an estimated 920 million in FY 2020 and is projected to grow at a CAGR of around 10% until FY 2026, predominantly on account of rising cases of fatal and chronic diseases.
Moreover, spread of COVID-19 pandemic is expected to create more opportunities, which is anticipated to drive the market growth during the forecast period. Furthermore, government initiatives of raising funds for the country s molecular department is also expected to positively influence the market in the coming years.
However, since the department requires high competence and professional skillset, absence of the same can pose a hurdle. Also, with over 25% of the country s population being below poverty line and the rest of the population is either middle-class or lower middle-class, lack of funds and high cost of molecular diagnostics is also expected to hinder the growth of the market